Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
miRNAs remain investigational targets in AF remodeling; leaves open the need for validation trials before any clinical consideration.
Atrial fibrillation (AF) remains one of the leading causes of morbidity and mortality in the world which are related to palpitations, fainting, congestive heart failure or stroke. The mechanism for atrial fibrillation has been identified as electrical remodeling, structure remodeling and intracellular calcium handling remodeling. microRNAs (miRNAs) have recently emerged as one of the important factors in regulating gene expression. So far, thousands of miRNA genes have been found in diverse animals with the function of regulating cell death, cell proliferation, haematopoiesis and even participate in the processing of cardiovascular disease. In this review, we summarize the mechanism of AF and the association of microRNAs network with AF. We provide a potential perspective of miRNAs as the therapeutic target for AF.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: